Amf Tjanstepension Ab Vertex Pharmaceuticals Inc Transaction History
Amf Tjanstepension Ab
- $13.7 Billion
- Q4 2024
A detailed history of Amf Tjanstepension Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Amf Tjanstepension Ab holds 67,757 shares of VRTX stock, worth $33.9 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
67,757
Previous 167,918
59.65%
Holding current value
$33.9 Million
Previous $78.1 Million
65.06%
% of portfolio
0.2%
Previous 0.58%
Shares
28 transactions
Others Institutions Holding VRTX
# of Institutions
1,760Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.2 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.6 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.99 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.21 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $128B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...